LivaNova PLC

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

LIVNNASDAQ
HealthcareMedical - Devices
$80.70
$1.09(1.33%)
U.S. Market opens in 6h 20m

LivaNova PLC (LIVN)

Meyka AI Score

Z

Key Financials

Market Cap4.4B
P/E Ratio40.72
EPS (TTM)$4.00
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$82.09
3 Months$93.16
1 Year Target$79.24

LIVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LivaNova PLC (LIVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $79.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 40.72 and a market capitalization of 4.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.33%
5-Day Change
-2.21%
1-Month Change
2.80%
3-Month Change
20.23%
6-Month Change
29.93%
Year-to-Date (YTD) Change
31.16%
1-Year Change
89.70%
3-Year Change
53.54%
5-Year Change
6.16%
All-Time (Max) Change
15.40%

Contact Information

44 20 3325 0660
20 Eastbourne Terrace, London, GL, W2 6LG

Company Facts

33,000 Employees
IPO DateOct 19, 2015
CountryGB
Actively Trading

Frequently Asked Questions